Surgical resection and radiofrequency ablation initiate cancer in cytokeratin-19+-liver cells deficient for p53 and Rb
dc.contributor.author | Matondo, R. B. | |
dc.contributor.author | Toussaint, M. J. M. | |
dc.contributor.author | Govaert, K.M. | |
dc.contributor.author | Vuuren, L. D. | |
dc.contributor.author | Nantasanti, S. | |
dc.contributor.author | Nijkamp, M. W. | |
dc.contributor.author | Pandit, S. K. | |
dc.contributor.author | Tooten, P. C. J. | |
dc.contributor.author | Koster, M. H. | |
dc.contributor.author | Holleman, K. | |
dc.contributor.author | Schot, A. | |
dc.contributor.author | Gu, G. | |
dc.contributor.author | Spee, B. | |
dc.contributor.author | Roskams, T. | |
dc.contributor.author | Borel, R. I. | |
dc.contributor.author | Schotanus, B. | |
dc.contributor.author | Kranenburg, O. | |
dc.contributor.author | de Bruin, A. | |
dc.date.accessioned | 2018-10-09T06:23:14Z | |
dc.date.available | 2018-10-09T06:23:14Z | |
dc.date.issued | 2016-08-23 | |
dc.description.abstract | The long term prognosis of liver cancer patients remains unsatisfactory because of cancer recurrence after surgical interventions, particularly in patients with viral infections. Since hepatitis B and C viral proteins lead to inactivation of the tumor suppressors p53 and Retinoblastoma (Rb), we hypothesize that surgery in the context of p53/Rb inactivation initiate de novo tumorigenesis. We, therefore, generated transgenic mice with hepatocyte and cholangiocyte/ liver progenitor cell (LPC)-specific deletion of p53 and Rb, by interbreeding conditional p53/Rb knockout mice with either Albumin-cre or Cytokeratin-19-cre transgenic mice. We show that liver cancer develops at the necrotic injury site after surgical resection or radiofrequency ablation in p53/Rb deficient livers. Cancer initiation occurs as a result of specific migration, expansion and transformation of cytokeratin- 19+-liver (CK-19+) cells. At the injury site migrating CK-19+ cells formed small bile ducts and adjacent cells strongly expressed the transforming growth factor β (TGFβ). Isolated cytokeratin-19+ cells deficient for p53/Rb were resistant against hypoxia and TGFβ-mediated growth inhibition. CK-19+ specific deletion of p53/Rb verified that carcinomas at the injury site originates from cholangiocytes or liver progenitor cells. These findings suggest that human liver patients with hepatitis B and C viral infection or with mutations for p53 and Rb are at high risk to develop tumors at the surgical intervention site. | en_US |
dc.description.sponsorship | NFP grant : R.B.M., DU.282001.1.3 | en_US |
dc.identifier.other | PMID: 27323406 | |
dc.identifier.uri | https://www.suaire.sua.ac.tz/handle/123456789/2616 | |
dc.language.iso | en | en_US |
dc.subject | Liver | en_US |
dc.subject | HCC | en_US |
dc.subject | Hepatocyte | en_US |
dc.subject | Hepatitis | en_US |
dc.subject | Hepatectomy | en_US |
dc.subject | Tumor | en_US |
dc.subject | Rb | en_US |
dc.subject | p53 | en_US |
dc.title | Surgical resection and radiofrequency ablation initiate cancer in cytokeratin-19+-liver cells deficient for p53 and Rb | en_US |
dc.type | Article | en_US |
dc.url | https://doi.org/10.18632/oncotarget.9952 | en_US |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Matondo_JCI85506.pdf
- Size:
- 6.89 MB
- Format:
- Adobe Portable Document Format
- Description:
- Main article and supporting information
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.66 KB
- Format:
- Item-specific license agreed upon to submission
- Description: